Pharmaceutical
Manufacturing
Health
Eli Lilly
$116.799876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$116.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.02 (-0.02%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Eli Lilly and other stocks, options, ETFs, and crypto commission-free!
About
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. Read More The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.
Employees
38,680
Headquarters
Indianapolis, Indiana
Founded
1876
Market Cap
113.46B
Price-Earnings Ratio
46.66
Dividend Yield
1.94
Average Volume
7.46M
High Today
$117.54
Low Today
$116.45
Open Price
$117.42
Volume
749.39K
52 Week High
$132.13
52 Week Low
$81.65
Collections
Pharmaceutical
Manufacturing
Health
Health And Wellness
Pharmacies
Therapy
Medical
Healthcare
News
Yahoo FinanceMay 22
Eli Lilly says lower-priced insulin is now available
Yahoo Finance's Alexis Christoforous and Brian Sozzi speak to Christi Shaw, President of Eli Lilly Bio-Medicines about the company's low cost insulin drug and new line of migraine drugs.
Washington PostMay 22
Lilly selling half-price version of popular Humalog insulin
FILE - This April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. A half-price version of Eli Lilly’s popular Humalog insulin is now available, following the company’s promise in March to offer diabetics a more affordable option amid fierce criticism of soaring insulin prices. Lilly, one of the three top insulin makers, said Wednesday, May 22, 2019, that it’s begun selling its own generic version of Humalog U-100 under the chemical name, Insulin Lispro. (Darron Cummi...
Price Paid on Robinhood
13% Higher
Right Now
52 Week Low
$81.65
Average Price Paid
$103.38
52 Week High
$132.13
Earnings
$1.03
$1.19
$1.34
$1.50
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Jul 30, Pre-Market